On February 1, 2023 Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction ("PCR")-based technologies, reported that it will release financial results for the three months ended December 31, 2022, after the market closes on Thursday, February 9, 2023 (Press release, Applied DNA Sciences, FEB 1, 2023, View Source;id=253561&p=2256785&I=1206939-c7Z3G6f3m8 [SID1234626751]). The Company will host a conference call for the investment community to discuss its results and answer questions at 4:30 p.m. ET.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Date & Time: Thursday, February 9 @ 4:30 p.m. ET
Dial In (ask to be joined into the Applied DNA Sciences call):
Domestic callers (toll free): 844-887-9402
Canadian callers (toll free): 866-605-3852
International callers: 412-317-6798
Live webcast: View Source
A telephonic replay of the conference call will be available for 1 week following the conclusion of the live call:
Replay for domestic callers (toll free): 877-344-7529, replay access code 2079390
Replay for Canadian callers: 855-669-9658, replay access code 2079390
An archived webcast replay of the conference call will be available for 1 year following the conclusion of the live call: View Source
An accompanying slide presentation will be embedded in the webcast (live and replay) and can also be accessed in the ‘Company Events’ section of the ‘News & Events’ tab of the Applied DNA investor relations website at View Source